S. Quint et al., Set-up verification of cervix cancer patients treated with long treatment fields; implications of a non-rigid bony anatomy, RADIOTH ONC, 60(1), 2001, pp. 25-29
Citations number
19
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Onconogenesis & Cancer Research
Background and purpose: For cervix cancer patients, treatment fields may ex
tend up to vertebra L1. In clinical practice, set-up verification is based
on measured displacements of the pelvic rim as visible in the caudal part o
f the treatment fields. The implications of this procedure for the position
s of bony structures in the cranial part of the fields were investigated.
Materials and methods: Twelve patients had four repeat simulator sessions.
Both during treatment simulation (the reference) and the repeat sessions, a
nterior radiographs were acquired covering the whole treatment field. The f
ilms were used to investigate differences between the cranial and the cauda
l parts of the treatment field in day-to-day bony anatomy displacements.
Results: Both in the transversal and the longitudinal directions, these dif
ferences were significant (3.5 mm, 1 SD). Indications were found that large
differences in the cranio-caudal direction may be correlated with (non-rig
id) internal pelvic rim rotations around a lateral axis. In the longitudina
l direction, the position of LI correlated much better with the position of
vertebra S1 than with the position of the pelvic rim, which is usually use
d for set-up verification.
Conclusions: Due to the non-rigid bony anatomy of the studied patients, the
usual set-up verification and correction procedure can result in set-up er
rors of 10 mm and more for structures in the cranial part of the treatment
field, even in the case of a perfect set-up of the pelvic rim. Possibly, ot
her patient set-up and immobilization procedures may result in a better day
-to-day reproducibility of the 3D bony anatomy shape. (Remaining) Differenc
es in anatomy position changes between the caudal and cranial field ends ma
y be accounted for by using non-uniform clinical target volume-to-planning
target volume margins, or by an adapted patient set-up verification and cor
rection protocol. (C) 2001 Elsevier Science Ireland Ltd. All rights reserve
d.